News

Eli Lilly Positioned To Dominate Obesity Market With Oral Option, Analyst Initiates With Confidence
Eli Lilly gains analyst support after Phase 3 success. Bullish forecasts for obesity dominance and key earnings are set for ...
News 93h
Discounts available for weight loss drugs not covered by insurance
In this edition of Daily Dose, Dr. Lacy Anderson answers a viewer's question about what discounts are available for weight ...
Cheaper copycat GLP-1 weight-loss drugs are disappearing: What to do if you're taking them
Compounded Ozempic and Wegovy, cheaper generic versions of the weight-loss drugs, can no longer be sold. Doctor explains ...
The complex legacy left by Pope Francis and Harvard fights back against the Trump administration: Morning Rundown
Plus, salon owners are seeing a massive drawdown in clients coming in for their regular scheduled appointments, citing ...
Generic weight-loss drugs to come off the market: What to know
Less expensive versions of popular weight-loss medications like Wegovy and Zepbound are soon going to be taken off the market. NBC News medical contributor Dr. Natalie Azar joins TODAY to explain what ...
What to know about GLP-1 supplements for weight loss
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...